Rex Genia Life Sciences Private Limited
About Rex Genia Life Sciences Private Limited
Data last updated:
Rex Genia Life Sciences Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 April 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2016PTC280451. Its GSTIN is 27AAHCR7695C1ZZ (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5.85 Lakh. It is led by directors including Parvatamma Basapuram and Sale Jaya Ram.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.71 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹15.7 Lakh (net margin 4.2%) and EBITDA of ₹44.79 Lakh (EBITDA margin 12.1%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 6% over five years.
As per MCA filings, the company has satisfied charges of ₹95 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address1312 13th Floor Hubtown Solaris Ns Phadke, Nr Flyover Bridge Andheri East, Mumbai, Maharashtra, India – 400069
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Rex Genia Life Sciences Private Limited
The main business activity of Rex Genia Life Sciences is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Rex Genia Life Sciences Private Limited FY 2025 filings available
Rex Genia Life Sciences Private Limited reported revenue of ₹3.71 Cr (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Rex Genia Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 9% growth in the latest year. EBITDA rose 95% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Rex Genia Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹44.79 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹15.7 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Rex Genia Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Rex Genia Life Sciences are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Rex Genia Life Sciences Private Limited
Rex Genia Life Sciences Private Limited is compared with the companies closest to it by revenue in the Chemicals industry (Chemical Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jewel City Exports Private Limited | ₹3.72 Cr (FY 2022) | •••• | •••• | •••• | Surat, Gujarat, India | |
| Hygene Biosciences Private Limited | ₹3.72 Cr (FY 2024) | •••• | •••• | 13.0% | •••• | Chennai, Tamil Nadu, India |
| Ragi Impex Private Limited | ₹3.72 Cr (FY 2024) | •••• | •••• | 19.0% | •••• | Mumbai, Maharashtra, India |
| Kamataz Sourcing and Consulting Private Limited | ₹3.72 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | Mumbai, Maharashtra, India |
| Yiding Technology Private Limited | ₹3.71 Cr (FY 2025) | •••• | •••• | •••• | Chennai, Tamil Nadu, India | |
| Rex Genia Life Sciences Private Limited this company | ₹3.71 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Mumbai, Maharashtra, India |
| Gupta Inter-Chem Private Limited | ₹3.69 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Mumbai, Maharashtra, India |
| New Era Technique Private Limited | ₹3.68 Cr (FY 2024) | •••• | •••• | 24.0% | •••• | Delhi, India |
| Govind Formulation Private Limited | ₹3.68 Cr (FY 2023) | •••• | •••• | 53.0% | •••• | Ahmedabad, Gujarat, India |
| Aggarwal Publicity and Marketing Private Limited | ₹3.68 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | New Delhi, Delhi, India |
| Shree Giriraj Exim Private Limited | ₹3.68 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Haryana, India |
Peers are the five companies nearest above and the five nearest below Rex Genia Life Sciences by revenue in the Chemicals industry (Chemical Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Rex Genia Life Sciences Private Limited
Rex Genia Life Sciences Private Limited is audited by SREEKANTH UTLA for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SREEKANTH UTLA | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Rex Genia Life Sciences Private Limited
Rex Genia Life Sciences has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Parvatamma Basapuram Also directs: Surakshitha Healthcare Private Limited | Director | 30 Apr 2016 | 10 Years 5 Months | Current |
| Sale Jaya Ram | Director | 09 Dec 2020 | 5 Years 10 Months | Current |
| Kurva Joshi Raghavendraprasad | Director | 28 Feb 2022 | 4 Years 7 Months | Current |
Ownership and Shareholding of Rex Genia Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Rex Genia Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2017 | State Bank of India | ₹95 Lakh | Satisfied |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Rex Genia Life Sciences Private Limited
Rex Genia Life Sciences Private Limited has a workforce of 0 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Rex Genia Life Sciences Private Limited
Rex Genia Life Sciences Private Limited has 4 board changes on record since 2016: 3 appointments and 1 cessation. The latest: Lakshmiprasad Chape ceased to be Director on 01 Mar 2022.
Credit Ratings, Litigation & Regulatory Alerts for Rex Genia Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Rex Genia Life Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Rex Genia Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Rex Genia Life Sciences Private Limited
Rex Genia Life Sciences has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCR7695C1ZZ | Maharashtra | Active | 01 Jul 2017 |
| 36AAHCR7695C1Z0 | Telangana | Active | 07 Sep 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Rex Genia Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rex Genia Life Sciences Private Limited
Rex Genia Life Sciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 April 2016 (10+ years old) and is registered under CIN U24230MH2016PTC280451.
Rex Genia Life Sciences reported revenue of ₹3.71 Cr for FY 2025 (up 9% YoY).
Rex Genia Life Sciences has 3 current directors:
- Parvatamma Basapuram - Director
- Sale Jaya Ram - Director
- Kurva Joshi Raghavendraprasad - Director
Rex Genia Life Sciences reported a net profit of ₹15.7 Lakh (net margin 4.2%) and EBITDA of ₹44.79 Lakh (EBITDA margin 12.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Rex Genia Life Sciences is 4% over three years and 6% over five years. In the latest year (FY 2025) revenue rose 9%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Rex Genia Life Sciences is 27AAHCR7695C1ZZ, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 36AAHCR7695C1Z0 (Telangana).
The CIN (Corporate Identification Number) of Rex Genia Life Sciences is U24230MH2016PTC280451. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rex Genia Life Sciences was incorporated on 30 April 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Rex Genia Life Sciences by revenue are Jewel City Exports Private Limited, Hygene Biosciences Private Limited, Ragi Impex Private Limited, Kamataz Sourcing and Consulting Private Limited, Yiding Technology Private Limited and 5 more, all in the Chemicals industry (Chemical Retail and Distribution).
Lakshmiprasad Chape ceased to be Director on 01 Mar 2022. Kurva Joshi Raghavendraprasad was appointed as Director on 28 Feb 2022. Sale Jaya Ram was appointed as Director on 09 Dec 2020. Rex Genia Life Sciences has 4 board changes on record in total.
The registered office of Rex Genia Life Sciences is at 1312 13th Floor Hubtown Solaris Ns Phadke, Nr Flyover Bridge Andheri East, Mumbai, Maharashtra, India – 400069.